Biotech profit plan is OK’d:
<h3>State will share in firms' earnings based on fruits of university research.</h3><p class="source">Sacramento Bee</p>
<p>The royalty decision was a compromise. The biotech industry had pushed for a smaller royalty agreement. Taxpayer advocates wanted a more generous one. "I'm disappointed that they haven't been able to understand the importance of maintaining a payback to all the Californians who are coming up with this money," said John Simpson, stem cell project director for the Foundation for Taxpayer and Consumer Rights.</p>
